It is useful in preparation of morpholinopyrimidine derivatives as mTOR kinase inhibitors for the treatment of diseases mediated by mTOR kinase and/or one or more PI3K enzymes.
参考文献
PubChem文献
数据源提供
• Mease, P., et al.: Lancet, 356, 385 (2000)
• Bang, L., et al.: BioDrugs, 18, 121 (2000)
• Tracey, D., et al.: Pharmacol. Ther., 117, 244 (2000)
• O'Keefe, S., et al.: J. Biol. Chem., 282, 34663 (2000)